BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Akorn, Inc. (AMEX:AKN) and FDC Limited (MUMBAI:FDC), a leading ophthalmic drug company in India, today announced that they have signed an exclusive development and supply agreement for two ophthalmic suspension drug products. The two drug products currently have a combined U.S. market size of approximately $170 million.
